Summary
Samenvatting onderdeel reumatologie MOB IIIB
- Course
- Institution
Samenvatting reumatologie, onderdeel van het grotere vak, MOB IIIB.
[Show more]
Seller
Follow
lunagauchez
Content preview
SAMENVATTING REUMATOLOGIEMODULE ONDERZOEK & BEHANDELING IIIB
INHOUDSOPGAVE
Inleiding ........................................................................................................................................................... 5
Wat is reumatologie? .......................................................................................................................................... 5
Belang van kinesitherapie? ................................................................................................................................. 5
Prognose ............................................................................................................................................................. 6
Anamnese en klinisch onderzoek ........................................................................................................................ 6
Pijntypes .......................................................................................................................................................... 7
Andere onderzoeken ....................................................................................................................................... 9
Het gewricht ...................................................................................................................................................... 11
Gewrichtskraakbeen ..................................................................................................................................... 11
Synoviaal vocht ............................................................................................................................................. 12
Metabool - Degeneratieve aandoeningen ...................................................................................................... 13
Osteoporose ...................................................................................................................................................... 13
Definitie ......................................................................................................................................................... 13
Risicofactoren................................................................................................................................................ 14
Pathogenese.................................................................................................................................................. 15
Kinesitherapeutische aanpak ........................................................................................................................ 16
Overige behandelingen ................................................................................................................................. 17
Osteoartrose...................................................................................................................................................... 18
Definitie ......................................................................................................................................................... 18
Primair vs. secundair ..................................................................................................................................... 18
Klinisch beloop en symptomen ..................................................................................................................... 20
Diagnose ........................................................................................................................................................ 21
Radiografische kenmerken ............................................................................................................................ 22
Prognose ....................................................................................................................................................... 22
Behandeling .................................................................................................................................................. 22
Weke delen .................................................................................................................................................... 27
Fibromyalgie...................................................................................................................................................... 27
Definitie ......................................................................................................................................................... 27
Epidemiologie................................................................................................................................................ 28
Diagnose ........................................................................................................................................................ 28
Pathogenese.................................................................................................................................................. 30
Behandeling .................................................................................................................................................. 31
, Prognose ....................................................................................................................................................... 35
Spierletsels ........................................................................................................................................................ 36
Gradaties ....................................................................................................................................................... 36
Diagnose ........................................................................................................................................................ 36
Behandeling – acuut...................................................................................................................................... 36
Prognose ....................................................................................................................................................... 37
Peesletsels ......................................................................................................................................................... 38
Terminologie ................................................................................................................................................. 38
Oorzaken ....................................................................................................................................................... 38
Opbouw ......................................................................................................................................................... 39
Pathologenese............................................................................................................................................... 39
Diagnose ........................................................................................................................................................ 40
Locaties - meestvoorkomende ...................................................................................................................... 40
Behandeling – algemeen ............................................................................................................................... 41
Fricties ........................................................................................................................................................... 41
Aanpak van risicofactoren ............................................................................................................................. 41
Actieve revalidatie......................................................................................................................................... 42
Oefentherapie Achillespees .......................................................................................................................... 42
Oefentherapie patellapees ........................................................................................................................... 42
Evidentie ....................................................................................................................................................... 43
Bursitis ............................................................................................................................................................... 44
Diagnose ........................................................................................................................................................ 45
Behandeling .................................................................................................................................................. 45
Inklemmingsneuropathie .................................................................................................................................. 47
Definitie ......................................................................................................................................................... 47
Diagnose ........................................................................................................................................................ 47
Lokalisatie...................................................................................................................................................... 47
Behandeling .................................................................................................................................................. 47
Complex Regionaal Pijn Syndroom (CRPS) ........................................................................................................ 48
Epidemiologie................................................................................................................................................ 48
Terminologie ................................................................................................................................................. 48
Kliniek ............................................................................................................................................................ 48
Diagnose ........................................................................................................................................................ 49
Pathofysiologie .............................................................................................................................................. 50
Behandeling .................................................................................................................................................. 50
Prognose ....................................................................................................................................................... 52
Preventie ....................................................................................................................................................... 52
Systeemziekten of bindweefselaandoeningen ............................................................................................... 53
Lupus – Systemic Lupus Erythematosus (SLE) ................................................................................................... 53
Epidemiologie................................................................................................................................................ 53
Kliniek ............................................................................................................................................................ 53
Diagnose ........................................................................................................................................................ 55
Belangrijkste ANtilichamen ........................................................................................................................... 56
Pathogenese.................................................................................................................................................. 57
Behandeling .................................................................................................................................................. 57
Prognose ....................................................................................................................................................... 58
, Intermezzo corticosteroiden* ....................................................................................................................... 59
Intermezzo raynaud** .................................................................................................................................. 60
Sjögren syndroom ............................................................................................................................................. 61
Epidemiologie................................................................................................................................................ 61
Kliniek ............................................................................................................................................................ 61
Diagnose ........................................................................................................................................................ 62
Behandeling .................................................................................................................................................. 62
Sclerodermie – systemic sclerodermia .............................................................................................................. 64
Epidemiologie................................................................................................................................................ 64
Pathofysiologie .............................................................................................................................................. 64
Kliniek ............................................................................................................................................................ 64
Diagnose ........................................................................................................................................................ 66
(Mal)nutritie .................................................................................................................................................. 67
Behandeling .................................................................................................................................................. 67
Prognose ....................................................................................................................................................... 68
Polymyositis Dermatomyositis .......................................................................................................................... 69
Terminologie ................................................................................................................................................. 69
Epidemiologie................................................................................................................................................ 69
Kliniek ............................................................................................................................................................ 70
Diagnose ........................................................................................................................................................ 71
Technische onderzoeken............................................................................................................................... 71
Differentiaal diagnose ................................................................................................................................... 71
Behandeling .................................................................................................................................................. 72
Prognose ....................................................................................................................................................... 72
Ehlers Danlos ..................................................................................................................................................... 73
Kinesitherapie ............................................................................................................................................... 73
Inflammatoire reuma ..................................................................................................................................... 74
Reumatoide artritis ........................................................................................................................................... 74
Definitie ......................................................................................................................................................... 74
Epidemiologie................................................................................................................................................ 74
Pathofysiologie .............................................................................................................................................. 74
Kliniek ............................................................................................................................................................ 75
Pathogenese.................................................................................................................................................. 77
Diagnose ........................................................................................................................................................ 78
Behandeling .................................................................................................................................................. 80
Prognose ....................................................................................................................................................... 87
Spondyl-artropathieën ...................................................................................................................................... 88
Psoriasis artritis ............................................................................................................................................. 88
Ziekte van Bechterew - Spondylytis ANkylosans ........................................................................................... 92
Infecties en artritis ........................................................................................................................................ 99
Stofwisselingsreuma .................................................................................................................................... 100
Jicht (gout)....................................................................................................................................................... 100
Definitie ....................................................................................................................................................... 100
Epidemiologie.............................................................................................................................................. 100
Pathogenese................................................................................................................................................ 100
, Kliniek en stadia .......................................................................................................................................... 100
Diagnose ...................................................................................................................................................... 102
Behandeling ................................................................................................................................................ 103
Prognose ..................................................................................................................................................... 103
Chondrocalcinosis – pseudo-jicht .................................................................................................................... 104
Definitie / Epidemiologie ............................................................................................................................ 104
Kliniek .......................................................................................................................................................... 104
Risicofactoren.............................................................................................................................................. 104
Diagnose ...................................................................................................................................................... 105
Behandeling ................................................................................................................................................ 105
Ziekte van Paget – osteitis deformans ........................................................................................................ 106
Casussen ...................................................................................................................................................... 108
ARTROSE .......................................................................................................................................................... 109
FIBROMYALGIE ................................................................................................................................................ 109
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller lunagauchez. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $6.86. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
51036 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 15 years now